Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 1/20 | 0.31 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.31 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.31 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.31 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9598979 | 1.00 | AR (0.31) | ARCHRNB2CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL9654110 | 0.84 | AR (0.31) | AR | |
| SCHEMBL11172350 | 0.83 | HTR2C (0.40) | AR | |
| Hydrochloric Acid SCHEMBL10596804 | 0.83 | AR (0.30) | AR | |
| SCHEMBL11169777 | 0.83 | HTR1D (0.40) | AR | |
| SCHEMBL31170704 | 0.83 | HTR2C (0.40) | AR | |
| SCHEMBL10841291 | 0.83 | AR (0.30) | AR | |
| SCHEMBL14826475 | 0.82 | ALDH1A1 (0.35) | AR | |
| SCHEMBL9035367 | 0.81 | BRD4 (0.37) | ARCHRNB2CHRNB4CHRNA3CHRNA7 | |
| SCHEMBL9582630 | 0.81 | BRD4 (0.37) | ARCHRNB2CHRNB4CHRNA3CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114890945-B | Method for synthesizing nadifloxacin intermediate | 大连万福制药有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-114890945-A | Method for synthesizing nadifloxacin intermediate | 大连万福制药有限公司 | 2022-08-12 | — | — | CN | claimed |
| CN-114436956-A | Preparation method and detection method of 5, 6-difluoro-2-methyl-1, 2,3, 4-tetrahydroquinoline | 山东诚汇双达药业有限公司 | 2022-05-06 | — | — | CN | claimed |
| CN-113527358-B | Synthesis process of S- (-) -nadifloxacin chiral intermediate | 湖南中威制药有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-114890945-B | Method for synthesizing nadifloxacin intermediate | 大连万福制药有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-114890945-A | Method for synthesizing nadifloxacin intermediate | 大连万福制药有限公司 | 2022-08-12 | — | — | CN | disclosed |
| CN-114436956-A | Preparation method and detection method of 5, 6-difluoro-2-methyl-1, 2,3, 4-tetrahydroquinoline | 山东诚汇双达药业有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-114436956-A | Preparation method and detection method of 5, 6-difluoro-2-methyl-1, 2,3, 4-tetrahydroquinoline | 山东诚汇双达药业有限公司 | 2022-05-06 | — | — | CN | disclosed |
| CN-114436956-A | Preparation method and detection method of 5, 6-difluoro-2-methyl-1, 2,3, 4-tetrahydroquinoline | 山东诚汇双达药业有限公司 | 2022-05-06 | — | — | CN | disclosed |